Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1998 1
2007 2
2008 2
2009 4
2010 3
2011 1
2012 2
2013 5
2014 6
2015 11
2016 12
2017 21
2018 14
2019 15
2020 18
2021 27
2022 23
2023 19
2024 13
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
Tirzepatide: A Review in Type 2 Diabetes.
France NL, Syed YY. France NL, et al. Among authors: syed yy. Drugs. 2024 Feb;84(2):227-238. doi: 10.1007/s40265-023-01992-4. Epub 2024 Feb 23. Drugs. 2024. PMID: 38388874 Review.
Sacituzumab Govitecan: First Approval.
Syed YY. Syed YY. Drugs. 2020 Jul;80(10):1019-1025. doi: 10.1007/s40265-020-01337-5. Drugs. 2020. PMID: 32529410 Free PMC article. Review.
Tirzepatide: First Approval.
Syed YY. Syed YY. Drugs. 2022 Jul;82(11):1213-1220. doi: 10.1007/s40265-022-01746-8. Drugs. 2022. PMID: 35830001 Review.
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries.
Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, Lascarrou JB, Szuldrzynski K, Camporota L, Pelosi P, Sorbello M, Higgs A, Greif R, Putensen C, Agvald-Öhman C, Chalkias A, Bokums K, Brewster D, Rossi E, Fumagalli R, Pesenti A, Foti G, Bellani G; INTUBE Study Investigators. Russotto V, et al. JAMA. 2021 Mar 23;325(12):1164-1172. doi: 10.1001/jama.2021.1727. JAMA. 2021. PMID: 33755076 Free PMC article.
Revumenib: First Approval.
Syed YY. Syed YY. Drugs. 2025 Apr;85(4):577-583. doi: 10.1007/s40265-025-02161-5. Drugs. 2025. PMID: 40072775 Review.
Olezarsen: First Approval.
Syed YY. Syed YY. Drugs. 2025 Apr;85(4):571-576. doi: 10.1007/s40265-025-02166-0. Epub 2025 Mar 13. Drugs. 2025. PMID: 40074987 Review.
Catumaxomab: First Approval.
Syed YY. Syed YY. Drugs. 2025 Jul;85(7):957-963. doi: 10.1007/s40265-025-02187-9. Epub 2025 Apr 30. Drugs. 2025. PMID: 40304879 Review.
205 results